Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?

Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?

The incidence and clinical presentation of ischemic heart disease (IHD), as well as thrombotic and bleeding risks, appear to differ between genders. Compared with men, women feature an increased thrombotic risk, probably related to an increased platelet reactivity, higher level of coagulation factor...

Full description

Bibliographic Details
Main Authors: Renzo Laborante, Josip Andjelo Borovac, Mattia Galli, Daniele Rodolico, Giuseppe Ciliberti, Attilio Restivo, Luigi Cappannoli, Alessandra Arcudi, Rocco Vergallo, Andrea Zito, Giuseppe Princi, Antonio Maria Leone, Cristina Aurigemma, Enrico Romagnoli, Rocco Antonio Montone, Francesco Burzotta, Carlo Trani, Domenico D’Amario
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
antithrombotic therapy
antiplatelet therapy
anticoagulant therapy
ischemic heart disease
gender differences
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1009475/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1009475/full

Similar Items